Gardasil vaccine may cause premature ovarian failure in some girls.

The American College of Pediatricians is committed to the health and wellbeing of children. That’s why they feel the need to inform the public about potential risks associated with this vaccine. Gardasil has been approved by the FDA and the TGA. It is given to school age girls and boys in most countries of the world. Some researchers believe it hasn’t been tested adequately for safety.

There have been several documented cases of premature ovarian failure (POF) in adolescent girls which developed weeks to years after receiving the Gardasil vaccine. There is also an association between premature ovarian failure and Cervarix (the two strain vaccine), but it is weaker. Premature ovarian failure causes premature menopause. The ovaries are unable to continue secreting hormones, thus levels fall to those consistent with menopause. This condition results in infertility. Obviously a diagnosis like this would be devastating for an adolescent girl.

The College has identified a number of issues that seriously question the safety of these vaccines. Here is a statement from their press release:

“(1) long-term ovarian function was not assessed in either the original rat safety studies or in the human vaccine trials, (2) most primary care physicians are probably unaware of a possible association between HPV4 and premature ovarian failure and may not consider reporting POF cases or prolonged amenorrhea (missing menstrual periods) to the Vaccine Adverse Event Reporting System (VAERS), (3) potential mechanisms of action have been postulated based on autoimmune associations with the aluminum adjuvant used and previously documented ovarian toxicity in rats from another component, polysorbate 80, and (4) since licensure of Gardasil® in 2006, there have been about 213 vaccine adverse events reports (per the publicly available CDC WONDER VAERS database) involving amenorrhea, POF or premature menopause, 88% of which have been associated with Gardasil®.5 The two-strain HPV2, CervarixTM, was licensed late in 2009 and accounts for 4.7 % of vaccine adverse events amenorrhea reports since 2006, and 8.5% of those reports from February 2010 through May 2015. This compares to the pre-HPV vaccine period from 1990 to 2006 during which no cases of POF or premature menopause and 32 cases of amenorrhea were reported.”

Polysorbate 80 is a synthetic chemical added to the cervical cancer vaccine which is not found in most other vaccines. Many researchers believe it and aluminum are responsible for the adverse events associated with the vaccine. The American College of Pediatricians is a well respected authority and I believe more research is critically required to determine both the safety and efficacy of this vaccine.

Read more